| Time Period | Price Change (USD) | Price Change (%) |
|---|---|---|
| Today | $ 0.000010 | +0.03% |
| 30 Days | $ -0.0040 | -12.64% |
| 60 Days | $ -0.030 | -51.69% |
| 90 Days | $ 0.0096 | +52.56% |
BIO PROTOCOL (BIO) is the native utility and governance token of Bio Protocol, a crypto project focused on coordinating biotechnology research funding, liquidity, and community curation. The project sits in the BIO Protocol DeSci ecosystem, where BioDAOs, researchers, patients, builders, and token holders can help select and support science-focused initiatives. Instead of presenting biotechnology as a closed institutional pipeline, Bio Protocol uses token-based governance and project launch infrastructure to organize early-stage funding and participation around biotech research, scientific data, and intellectual property.
For a KCEX price page, BIO is best understood as a token connected to on-chain science and tokenized biotech activity rather than a general payment coin. Its relevance to the RWA narrative comes from its focus on research assets, biotech IP, project treasuries, and funding flows tied to real-world scientific development. BIO price interest may therefore reflect both crypto market conditions and demand for tokenized access to biotech innovation.
The BIO Protocol DeSci ecosystem is built around community curation, project funding, liquidity support, and milestone-based incentives. BIO token holders can stake BIO for veBIO, which is used for governance participation and alignment with longer-term protocol decisions. Staked participants help decide which biotech projects may enter the network, and accepted projects can then use Bio Protocol launch and support mechanisms to raise attention, funding, and community participation.
BIO also functions as an ecosystem coordination asset. It may be used in new project launches, liquidity structures, and access to specialized services such as BioAgents. The protocol describes core operations that include selection, funding, liquidity, transparency, and support, giving BIO a role beyond simple transfer activity. Liquidity is especially important because Bio Protocol aims to help project tokens and biotech-related assets trade more efficiently while allowing researchers to focus on scientific progress. Governance frameworks and milestone-linked incentives are designed to connect token participation with verifiable development, which is important when real-world research timelines are uncertain and capital-intensive.
Within the BIO Protocol DeSci ecosystem, BIO is used for governance, staking, project curation, launch participation, liquidity support, and access to protocol services. Common long-tail search topics include BIO Protocol token utility, BIO crypto DeSci use cases, BioDAO funding with BIO, BIO Protocol governance token, and tokenized biotech research crypto. These phrases reflect how users typically evaluate whether BIO is connected to practical network activity or only market speculation.
Concrete use cases include voting on ecosystem project selection, aligning stakeholders through veBIO, supporting early biotech initiatives, and helping create liquidity for BioDAO-related tokens. BIO may also be relevant for users researching crypto exposure to tokenized scientific IP, biotech project treasuries, decentralized research communities, and real-world research funding models. Its utility depends on continued activity across the protocol, BioDAOs, and supported research projects.
BIO PROTOCOL (BIO) value is influenced by BIO Protocol DeSci ecosystem growth, token utility, governance participation, liquidity conditions, biotech project adoption, broader market demand, and RWA-related attention toward tokenized assets. Because BIO is linked to research funding and BioDAO activity, demand may respond to both crypto-native usage and confidence in the protocol’s ability to coordinate real-world scientific outcomes.
Institutional Adoption matters because biotechnology research is traditionally shaped by universities, venture funds, pharmaceutical companies, and grant organizations. If credible institutions, researchers, or professional investors engage with the BIO Protocol DeSci ecosystem, it can improve perceived legitimacy, attract higher-quality projects, and deepen demand for BIO governance and launch participation. Weak institutional engagement can limit trust and reduce participation from serious research stakeholders.
Tokenized Asset Growth is important for BIO because Bio Protocol is connected to tokenized biotech projects, research data, and intellectual property pathways. As more real-world research assets move into transparent on-chain funding and liquidity structures, BIO may benefit from greater ecosystem activity. If tokenized biotech projects fail to gain traction, the utility of BIO for curation, liquidity, and project launches may grow more slowly.
Regulatory Environment can strongly affect BIO because biotech funding, scientific IP, token launches, and community participation may intersect with securities, healthcare, data, and research rules. Clearer regulation can support compliant project design and broader adoption. Uncertainty or restrictive rules may reduce capital flows, limit participation in project launches, or increase operational complexity for the BIO Protocol DeSci ecosystem.
Treasury Yield Demand influences the broader RWA market because investors often compare tokenized asset opportunities with lower-risk yield sources. For BIO, this matters indirectly: if market participants prefer yield-bearing treasury products, speculative funding for early biotech projects may face competition. However, strong demand for real-world yield can also educate users about tokenized assets, making research-linked crypto models easier to understand.
Capital Inflows are central to BIO because biotechnology development requires sustained funding. More capital entering DeSci, tokenized research, and BioDAO treasuries can increase project launches, liquidity needs, and governance activity. Reduced inflows can slow ecosystem expansion, weaken liquidity, and lower demand for BIO utility. For price pages, this factor helps explain why BIO may react to both sector sentiment and protocol-level funding activity.
BioDAO curation and launch activity is a coin-specific value driver because BIO holders help select which biotech projects enter the ecosystem. More credible project applications, successful launches, and active BioDAO communities can increase the usefulness of BIO staking and governance. If curation quality declines or launches attract limited participation, BIO’s role as a coordination asset may become less compelling.
veBIO staking and BioXP incentives are unique demand drivers within Bio Protocol’s token design. Staking can align participants with longer-term governance, while rewards can encourage contributions to ecosystem growth and scientific milestones. These mechanisms may support retention and participation, but their impact depends on transparent incentives, meaningful governance decisions, and continued activity across Bio Protocol projects and services.
BIO PROTOCOL (BIO) is currently trading at $0.027 USD on KCEX. This reflects a +1.49% change over the past 24 hours.
BIO PROTOCOL has a market capitalization of $59.88M USD, ranking #384 among all cryptocurrencies. Market cap is calculated by multiplying the current price by the circulating supply.
The current circulating supply of BIO is 2.15B out of a maximum supply of 3.32B. This means approximately 64.60% of all BIO that will ever exist is already in circulation.
BIO PROTOCOL reached its all-time high of $0.888995 USD on 2025-01-03. The current price is approximately 96.85% below that peak.
BIO PROTOCOL hit its all-time low of $0.01589991 USD on 2026-03-29. Since then, BIO has gained over 75.59% from that level.
You can buy BIO on KCEX by creating a free account, completing verification, and depositing funds via crypto transfer. BIO/USDT is available for both spot trading and futures trading on KCEX.
BIO PROTOCOL is currently priced at $0.027 USD with a 24h change of +1.49% and a 7-day change of -6.34%. Investment decisions depend on your own research and risk tolerance - always do your own due diligence before trading.
KCEX offers zero maker fees on BIO/USDT spot trading. Taker fees are among the lowest in the industry, making KCEX a cost-effective platform for trading BIO PROTOCOL. For a full breakdown of trading fees, visit the KCEX Fee Schedule.